Escalon Medical annual stock-based compensation
2011
2012
2013
2014
2015
2018
2019
Escalon Medical Stock-Based Compensation Growth & History (ESMC)
Escalon Medical's stock-based compensation was $0 for fiscal 2019.
View full Escalon Medical company overviewEscalon Medical annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-06-30 | $0 | $0 | — |
| 2018 | 2018-06-30 | $0 | — | — |
| 2015 | 2015-06-30 | $52,103 | $39,686 | +319.61% |
| 2014 | 2014-06-30 | $12,417 | −$31,553 | −71.76% |
| 2013 | 2013-06-30 | $43,970 | −$29,383 | −40.06% |
| 2012 | 2012-06-30 | $73,353 | −$37,701 | −33.95% |
| 2011 | 2011-06-30 | $111,054 | — | — |
Escalon Medical stock-based compensation trends
Over the last five fiscal years, Escalon Medical's stock-based compensation decreased from $12,417 to $0, a change of −$12,417.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Escalon Medical source filings ↗